Search details
1.
Impact of preventive pill-based treatment on migraine days: A secondary outcome study of the Childhood and Adolescent Migraine Prevention (CHAMP) trial and a comparison of self-report to nosology-derived assessments.
Headache
; 63(6): 805-812, 2023 06.
Article
in English
| MEDLINE | ID: mdl-36757131
2.
Trajectory of treatment response in the child and adolescent migraine prevention (CHAMP) study: A randomized clinical trial.
Cephalalgia
; 42(1): 44-52, 2022 01.
Article
in English
| MEDLINE | ID: mdl-34404270
3.
Multimodal Assessment of Medication Adherence Among Youth With Migraine: An Ancillary Study of the CHAMP Trial.
J Pediatr Psychol
; 47(4): 376-387, 2022 04 08.
Article
in English
| MEDLINE | ID: mdl-34865085
4.
Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis.
N Engl J Med
; 379(9): 846-855, 2018 08 30.
Article
in English
| MEDLINE | ID: mdl-30157388
5.
Safety and efficacy of N-acetylmannosamine (ManNAc) in patients with GNE myopathy: an open-label phase 2 study.
Genet Med
; 23(11): 2067-2075, 2021 11.
Article
in English
| MEDLINE | ID: mdl-34257421
6.
Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's Disease.
Ann Neurol
; 88(3): 574-587, 2020 09.
Article
in English
| MEDLINE | ID: mdl-32542885
7.
Longitudinal Analysis of Multiple Neurotransmitter Metabolites in Cerebrospinal Fluid in Early Parkinson's Disease.
Mov Disord
; 36(8): 1972-1978, 2021 08.
Article
in English
| MEDLINE | ID: mdl-33942926
8.
Improving natural product research translation: From source to clinical trial.
FASEB J
; 34(1): 41-65, 2020 01.
Article
in English
| MEDLINE | ID: mdl-31914647
9.
Neurofilament light chain in a phase 2 clinical trial of ibudilast in progressive multiple sclerosis.
Mult Scler
; 27(13): 2014-2022, 2021 11.
Article
in English
| MEDLINE | ID: mdl-33635141
10.
Optical coherence tomography outcomes from SPRINT-MS, a multicenter, randomized, double-blind trial of ibudilast in progressive multiple sclerosis.
Mult Scler
; 27(9): 1384-1390, 2021 08.
Article
in English
| MEDLINE | ID: mdl-33054533
11.
Trial of Amitriptyline, Topiramate, and Placebo for Pediatric Migraine.
N Engl J Med
; 376(2): 115-124, 2017 01 12.
Article
in English
| MEDLINE | ID: mdl-27788026
12.
Final Results of the RHAPSODY Trial: A Multi-Center, Phase 2 Trial Using a Continual Reassessment Method to Determine the Safety and Tolerability of 3K3A-APC, A Recombinant Variant of Human Activated Protein C, in Combination with Tissue Plasminogen Activator, Mechanical Thrombectomy or both in Moderate to Severe Acute Ischemic Stroke.
Ann Neurol
; 85(1): 125-136, 2019 01.
Article
in English
| MEDLINE | ID: mdl-30450637
13.
Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression.
Mov Disord
; 35(11): 1999-2008, 2020 11.
Article
in English
| MEDLINE | ID: mdl-32798333
14.
Clinical and Dopamine Transporter Imaging Characteristics of Leucine Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross-Sectional Study.
Mov Disord
; 35(5): 833-844, 2020 05.
Article
in English
| MEDLINE | ID: mdl-32073681
15.
Longitudinal analyses of cerebrospinal fluid α-Synuclein in prodromal and early Parkinson's disease.
Mov Disord
; 34(9): 1354-1364, 2019 09.
Article
in English
| MEDLINE | ID: mdl-31361367
16.
Natural history of infantile-onset spinal muscular atrophy.
Ann Neurol
; 82(6): 883-891, 2017 Dec.
Article
in English
| MEDLINE | ID: mdl-29149772
17.
Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson's disease: the PPMI cohort.
J Neurol Neurosurg Psychiatry
; 89(1): 78-88, 2018 01.
Article
in English
| MEDLINE | ID: mdl-28986467
18.
CSF biomarkers associated with disease heterogeneity in early Parkinson's disease: the Parkinson's Progression Markers Initiative study.
Acta Neuropathol
; 131(6): 935-49, 2016 06.
Article
in English
| MEDLINE | ID: mdl-27021906
19.
The Childhood and Adolescent Migraine Prevention (CHAMP) Study: A Report on Baseline Characteristics of Participants.
Headache
; 56(5): 859-870, 2016 May.
Article
in English
| MEDLINE | ID: mdl-27039826
20.
A post hoc evaluation of a sample size re-estimation in the Secondary Prevention of Small Subcortical Strokes study.
Clin Trials
; 13(5): 537-44, 2016 10.
Article
in English
| MEDLINE | ID: mdl-27094488